Topical Gel Soothes Skin Rash for CRC Patients on EGFR Inhibitors

Watchdoq April 30, 2025
(MedPage Today) -- The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients with advanced colorectal cancer who were treated with an epidermal growth factor receptor (EGFR)-targeted...

Read Full Article